Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23,996 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ticagrelor with or without aspirin in high-risk patients with anaemia undergoing percutaneous coronary intervention: a subgroup analysis of the TWILIGHT trial.
Spirito A, Kastrati A, Cao D, Baber U, Sartori S, Angiolillo DJ, Briguori C, Cohen DJ, Dangas G, Dudek D, Escaned J, Gibson CM, Zhang Z, Huber K, Kaul U, Kornowski R, Kunadian V, Han YL, Mehta SR, Sardella G, Sharma S, Shlofmitz RA, Vogel B, Collier T, Pocock S, Mehran R. Spirito A, et al. Among authors: sharma s. Eur Heart J Cardiovasc Pharmacother. 2023 Jun 2;9(4):328-336. doi: 10.1093/ehjcvp/pvad006. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 36649694 Clinical Trial.
Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximab.
Dangas G, Badimon JJ, Coller BS, Fallon JT, Sharma SK, Hayes RM, Meraj P, Ambrose JA, Marmur JD. Dangas G, et al. Among authors: sharma sk. Arterioscler Thromb Vasc Biol. 1998 Aug;18(8):1342-9. doi: 10.1161/01.atv.18.8.1342. Arterioscler Thromb Vasc Biol. 1998. PMID: 9714143 Clinical Trial.
23,996 results
You have reached the last available page of results. Please see the User Guide for more information.